ACC/AHA2020 Goff Junior DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith Junior SC, Sorlie P, Stone NJ, Wilson PWF. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63(25):2935-2959.
|
40-79 |
Age, sex, SBP, use of antihypertensive drugs, TC, HDL-c, DM, smoking |
Fatal coronary disease, non-fatal AMI and stroke |
≥ 7.5% |
Framingham (ERG)2121 D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-753.
|
30-74 |
Age, sex, SBP, use of antihypertensive drugs, TC, HDL-c, DM, smoking |
Fatal and non-fatal cardiovascular disease (coronary, cerebrovascular, heart failure, intermittent claudication) |
≥ 20% |
GRS - recommended by the BSC1919 Précoma DB, Oliveira GMM, Simão AS, Dutra OP, Coelho OR, Izar MCO, Póvoa RMS, Giuliano ICB, Alencar Filho AC, Machado CV, Scherr C, Fonseca FAH, Santos Filho RD, Carvalho T, Avezum Jr. A, Esporcatte R, Nascimento BR, Brasil DP, Soares GP, Villela PB, Ferreira RM, Martins WA, Sposito AC, Halpern B, Saraiva JFK, Carvalho LSF, Tambascia MA, Coelho-Filho OR, Bertolami A, Correa Filho H, Xavier HT, Faria-Neto JR, Bertolami MC, Giraldez VZR, Brandão AA, Feitosa ADM, Amodeo C, Souza DSM, Barbosa ECD, Malachias MVB, Souza WKSB, Costa FAA, Rivera IR, Pellanda LC, Silva MAM, Achutti AC, Langowiski AR, Lantieri CJB, Scholz JR, Ismael SMC, Ayoub JCA, Scala LCN, Neves MF, Jardim PCBV, Fuchs SCPC, Jardim TSV, Moriguchi EH, Schneider JC, Assad MHA, Kaiser SE, Lottenberg AM, Magnoni CD, Miname MH, Lara RS, Herdy AH, Araújo CGS, Milani M, Silva MMF, Stein R, Lucchese FA, Nobre F, Griz HB, Magalhães LBNC, Borba MHE, Pontes MRN, Mourilhe-Rocha R. Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia - 2019. Arq Bras Cardiol. 2019; 113(4):787-891.
|
30-74 |
Same as the GRS or subclinical atherosclerosis or abdominal aortic aneurysm or colesterol LDL-c ≥ 190 mg/dL or chronic kidney diseases or diabetes with LDL 70-190mg/dL and RS; SCA
|
Fatal and non-fatal cardiovascular disease (coronary, cerebrovascular, heart failure, intermittent claudication) |
≥ 10% women ≥ 20% men; plus other criteria |
WHO/ISH24
|
40-79 |
Age, sex, SBP, TC, DM, smoking |
Fatal or non-fatal AMI or stroke |
≥ 20% |
Lim et al.2323 Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007; 370(9604):2054-2062.
|
40-79 |
Age, sex, SBP, BMI, smoking |
Coronary disease or stroke (fatal) |
≥ 15% |
SCORE (High- Risk -TC)2222 Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov R G, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11):987-1003.
|
45-64 |
Age, sex, SBP, TC, smoking |
Cardiovascular death (coronary, stroke, arrhythmia, aortic aneurysm or peripheral vascular disease) |
≥ 5% |